Condition: Venous Thromboembolic Disease · Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Venous thromboembolism (VTE) and atherosclerotic cardiovascular disease share common risk factors and frequently coexist in the same patients. Their management requires use of antithrombotic agents: anticoagulant therapy (AC) for secondary prevention of VTE recurrence, antiplatelet (AP) for secondary prevention of major adverse ischemic cardiovascular and cerebrovascular event (MACCE) in patients with atherosclerotic cardiovascular disease (coronary artery disease, atherosclerotic cerebrovascular disease, lower extremity peripheral arterial disease). Side effects of antithrombotic drugs are the 1st cause of emergency admission and hospitalization for an adverse drug reaction (mainly bleeding), and the combination of AC with AP strongly increases this risk.
This description comes directly from the study's public registry record.
Laurent BERTOLETTI, MD PhD · (0)477829121 · laurent.bertoletti@chu-st-etienne.fr
Carine LABRUYERE · (0)477120469 · carine.labruyere@chu-st-etienne.fr
Always discuss trial participation with your own doctor first.
| CHU Amiens | Amiens, France | Recruiting |
| CHU Angers | Angers, France | Recruiting |
| CHU Besançon - Hôpital Jean Minjoz | Besançon, France | Recruiting |
| CHRU Brest - Hôpital la Cavale Blanche | Brest, France | Recruiting |
| Clinique du Parc - Castelnau-le -lez | Castelnau-le-Lez, France | Recruiting |
| CHU Clermont-Ferrand - Hôpital Gabriel Montpied | Clermont-Ferrand, France | Recruiting |
| CHU Dijon | Dijon, France | Recruiting |
| CH le Corbusier - Firminy | Firminy, France | Recruiting |
| CHU Grenoble - Hôpital la Tronche | Grenoble, France | Recruiting |
| CH Le Puy - Hôpital Emile Roux | Le Puy-en-Velay, France | Recruiting |
| CHU Limoges | Limoges, France | Recruiting |
| HCL - Hôpital Edouard Herriot | Lyon, France | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05627375